Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

NCT06605612 is registered in ClinicalTrials.gov with LMU Klinikum as lead sponsor.

NCT NCT06605612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06605612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
Lead sponsor
LMU Klinikum
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 9, 2024
Completion date
January 1, 2028
Enrollment
108 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, chronic inflammatory demyelinating polyneuropathy, friedreich ataxia, guillain-barré syndrome, hereditary motor sensory neuropathy, inclusion body myositis, lambert-eaton-syndrome, limb-girdle and facioscapulohumeral muscular dystrophies, myasthenia gravis, myotonic dystrophy, pompe disease, spinal muscular atrophy